FULCRUM THERAPEUTICS, INC. Shares Issued, Price Per Share
FULCRUM THERAPEUTICS, INC. (FULC) had Shares Issued, Price Per Share of $13.50 per share as of 2025-12-31, per its S-4 filed 2026-09-02.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:SharesIssuedPricePerShare · last filed 2026-09-02
- 2025-12-31: Shares Issued, Price Per Share $13.50; Shares Issued, Price Per Share as first filed $13.50.
- 2023-01-31: Shares Issued, Price Per Share $13.00.
- 2022-08-31: Shares Issued, Price Per Share $7.82.
- 2021-08-16: Shares Issued, Price Per Share $19.00.
| Period end | Shares Issued, Price Per Share | Shares Issued, Price Per Share as first filed |
|---|---|---|
| 2025-12-31 | $13.50 S-4 · filed 2026-09-02 | $13.50 10-K · filed 2026-02-24 |
| 2023-01-31 | $13.00 10-K · filed 2025-02-25 | |
| 2022-08-31 | $7.82 10-K · filed 2024-02-27 | |
| 2021-08-16 | $19.00 10-K/A · filed 2023-06-26 | |
| 2021-01-22 | $11.00 10-K/A · filed 2023-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |